leisure time -WSS

leisure time

author：entertainment 2025-09-05 09:16:42 - browse：59444

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Lifetime voting ban for felony convictions struck down in Mississippi

entertainment

focus

WSS

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Pediatricians' group reaffirms support for gender

Calls for Trump's election interference trial to be televised part of long debate

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Woman gored by Bison at Yellowstone

knowledge

leisure time

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Why police arrested suspected Gilgo Beach killer away from his house

Activists slam private health insurers over coverage restrictions

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

In Memoriam: Notable people who died in 2023

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

Activists slam private health insurers over coverage restrictions

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Apple is now the first public company to be valued at $3 trillion

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

hotspot

Care demand spikes challenge UnitedHealth’s provider arm

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Pharma needs to include young adults in clinical research

4 killed in mass shooting in Georgia, shooter remains on the loose: Police

Scientists find bacteria from stomach of ancient iceman

Federal judge rules Oregon’s tough new gun law is constitutional

entertainment

entertainment

focus

entertainment